NO169071C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-fenyl-3-(1h-1,2,4-triazol-1-ylmetyl)-5-substituerte-2-metylisoxazolidiner - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-fenyl-3-(1h-1,2,4-triazol-1-ylmetyl)-5-substituerte-2-metylisoxazolidinerInfo
- Publication number
- NO169071C NO169071C NO873607A NO873607A NO169071C NO 169071 C NO169071 C NO 169071C NO 873607 A NO873607 A NO 873607A NO 873607 A NO873607 A NO 873607A NO 169071 C NO169071 C NO 169071C
- Authority
- NO
- Norway
- Prior art keywords
- methylisoxazolidines
- triazol
- ylmethyl
- phenyl
- substituted
- Prior art date
Links
- -1 1H-1,2,4-TRIAZOL-1-YLMETHYL Chemical class 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/900,857 US4727157A (en) | 1986-08-27 | 1986-08-27 | 3-(Substituted phenyl)-3-(1H-1,2,4-triazol-1-yl)methyl-2-methyl-5-[(substituted phenoxy)methyl]isoxazolidine derivatives |
| US07/036,838 US4769471A (en) | 1987-04-10 | 1987-04-10 | Substituted 3,5-diphenyl-3-(1H-1,2,4-triazol-1-yl-methyl)-2-methylisoxazolidines |
| US07/036,831 US4767866A (en) | 1987-04-10 | 1987-04-10 | 3-Phenyl-3-(1H-1,2,4-triazol-1-ylmethyl)-2-methyl-5-alkylisoxazolidines |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO873607D0 NO873607D0 (no) | 1987-08-26 |
| NO873607L NO873607L (no) | 1988-02-29 |
| NO169071B NO169071B (no) | 1992-01-27 |
| NO169071C true NO169071C (no) | 1992-05-06 |
Family
ID=27365104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO873607A NO169071C (no) | 1986-08-27 | 1987-08-26 | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-fenyl-3-(1h-1,2,4-triazol-1-ylmetyl)-5-substituerte-2-metylisoxazolidiner |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0257351A3 (da) |
| KR (1) | KR880002864A (da) |
| AU (1) | AU596681B2 (da) |
| DK (1) | DK444787A (da) |
| FI (1) | FI873708A7 (da) |
| IL (1) | IL83273A0 (da) |
| NO (1) | NO169071C (da) |
| NZ (1) | NZ221116A (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL87797A0 (en) * | 1987-10-02 | 1989-03-31 | Pennwalt Corp | 5-mono or disubstituted-3-(phenyl or 2-naphthalenyl)-3-((1h-imidazol-1-ylmethyl)-and(1h-1,2,4-triazol-1-ylmethyl))-2-(methyl or benzyl)isoxazolidines |
| DE4013723A1 (de) * | 1990-04-28 | 1991-10-31 | Basf Ag | 5-(1,2,4-triazol-1-ylmethyl)-isoxazoline |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4870094A (en) * | 1984-05-02 | 1989-09-26 | Uniroyal Chemical Company, Inc. | Substituted imidazoles and triazoles |
| EP0192060B1 (de) * | 1985-02-04 | 1991-09-18 | Nihon Bayer Agrochem K.K. | Heterocyclische Verbindungen |
| IL87797A0 (en) * | 1987-10-02 | 1989-03-31 | Pennwalt Corp | 5-mono or disubstituted-3-(phenyl or 2-naphthalenyl)-3-((1h-imidazol-1-ylmethyl)-and(1h-1,2,4-triazol-1-ylmethyl))-2-(methyl or benzyl)isoxazolidines |
-
1987
- 1987-07-17 NZ NZ221116A patent/NZ221116A/en unknown
- 1987-07-21 IL IL83273A patent/IL83273A0/xx unknown
- 1987-07-31 EP EP87111130A patent/EP0257351A3/en not_active Withdrawn
- 1987-08-03 AU AU76522/87A patent/AU596681B2/en not_active Ceased
- 1987-08-26 DK DK444787A patent/DK444787A/da not_active Application Discontinuation
- 1987-08-26 NO NO873607A patent/NO169071C/no unknown
- 1987-08-26 KR KR870009310A patent/KR880002864A/ko not_active Withdrawn
- 1987-08-26 FI FI873708A patent/FI873708A7/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK444787D0 (da) | 1987-08-26 |
| NZ221116A (en) | 1990-01-29 |
| NO873607D0 (no) | 1987-08-26 |
| EP0257351A3 (en) | 1989-01-18 |
| AU7652287A (en) | 1988-03-03 |
| DK444787A (da) | 1988-02-28 |
| AU596681B2 (en) | 1990-05-10 |
| IL83273A0 (en) | 1987-12-31 |
| EP0257351A2 (en) | 1988-03-02 |
| KR880002864A (ko) | 1988-05-12 |
| NO169071B (no) | 1992-01-27 |
| NO873607L (no) | 1988-02-29 |
| FI873708A7 (fi) | 1988-02-28 |
| FI873708A0 (fi) | 1987-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO167202C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive (1h-imidazol-1-ylmetyl)-substituerte benzimidazolderivater. | |
| NO164025C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater. | |
| NO871267L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser. | |
| NO902633L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazolyl-alkensyrer. | |
| NO884473D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazoler. | |
| NO880182D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater. | |
| NO161497C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater. | |
| NO171412C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater | |
| NO883485D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser. | |
| NO164541C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater. | |
| NO893909L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater. | |
| NO890155L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser. | |
| NO880667D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser. | |
| NO884176D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive amidinoderivater. | |
| NO170085C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive (benzofuran-2-yl)imidazoler | |
| NO873680D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonamido-etyl-forbindelser. | |
| NO891046D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,2,4-triazol-derivater. | |
| NO162188C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner. | |
| NO168040C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3'-demetoksyepipodofyllotoksin-glukosidderivater. | |
| NO171211C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner | |
| NO174466C (no) | Analogifremgangsmåte for fremstilling av antiarrhytmisk aktive imidazoler | |
| NO165542C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner. | |
| NO166642C (no) | Anaolgifremgangsmaate for fremstilling av terapeutisk aktive 3-aryl-5-alkylthio-4h-1,2,4-triazoler. | |
| NO169071C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-fenyl-3-(1h-1,2,4-triazol-1-ylmetyl)-5-substituerte-2-metylisoxazolidiner | |
| NO162285C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolizinon-derivater. |